Skip to main content
. 2020 Feb 19;7(4):e249–e261. doi: 10.1016/S2352-3018(19)30433-3

Figure 4.

Figure 4

Adherence to PrEP estimated from the concentration of tenofovir in hair samples

Adherence at (A) week 4 (n=166) and (B) week 24 (n=152) among subgroups of sampled participants reporting self-assessed current HIV risk and any PrEP adherence (at least one dose taken of the past three). BLQ=below the limit of quantification.